T1	Participants 58 125	patients with relapsing-remitting multiple sclerosis: a multicentre
T2	Participants 562 612	The study was done in 51 centres in nine countries
T3	Participants 779 814	306 eligible patients were enrolled
T4	Participants 816 842	Patients, aged 18-50 years
